Intellego Technologies Updates On HAI Solutions' FDA Application

T-Reuters
27 Mar 2023

Intellego Technologies AB :Updates On Hai Solutions.End Product That Hai Sells Is Medical Device, Is Subject To Approval From Fda.Hai Will Shortly Submit Its Fda Application And Has In Dialogue With Fda Been Informed That Fda Approval For Application Should Come At End Of 2023.As Product Has Low Risk Classification, There Are No Significant Obstacles To Fda Authorisation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10